OmniAb Stock (NASDAQ: OABI) stock price, news, charts, stock research, profile.
Open | $4.620 |
Close | $4.560 |
Volume / Avg. | 557.392K / 479.639K |
Day Range | 4.535 - 4.625 |
52 Wk Range | 3.140 - 6.715 |
Market Cap | $534.095M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 28 |
Short Interest | 4.77% |
Days to Cover | 8.63 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of OmniAb (NASDAQ: OABI) through any online brokerage.
Other companies in OmniAb’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Quanterix (NASDAQ:QTRX).
The latest price target for OmniAb (NASDAQ: OABI) was reported by Truist Securities on Tuesday, March 26, 2024. The analyst firm set a price target for 10.00 expecting OABI to rise to within 12 months (a possible 119.30% upside). 7 analyst firms have reported ratings in the last year.
The stock price for OmniAb (NASDAQ: OABI) is $4.56 last updated April 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for OmniAb.
OmniAb’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for OmniAb.
OmniAb is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.